1. Ambrisentan Not Appropriate for Patients with Idiopathic Pulmonary Fibrosis Ambrisentan should not be used to treat patients for idiopathic pulmonary fibrosis (IPF). IPF is a fatal form of chronic, progressive lung disease characterized by irreversible scarring around both lungs. IPF causes about 5,000 deaths each year and currently there is no approved treatment. Researchers do not know what causes IPF, but a protein called endothelin-1 that causes the blood vessels to contract and induces lung scarring and proliferation has been associated with the disease...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment